Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
Become a Member | Sign in
Home>News>This Article

Thermo Fisher Scientific Names Recipients of RNAi Discovery Grants

Published: Friday, November 06, 2009
Last Updated: Friday, November 06, 2009
Bookmark and Share
More than $400,000 in RNAi screening tools awarded to advance biomedical research and drug discovery.

Thermo Fisher Scientific Inc has announced the recipients of more than $400,000 in RNA-interference (RNAi) reagents to advance biomedical research and drug discovery.

The awards were made through the Thermo Scientific RNAi Discovery Grant Program. Five projects were chosen based on the potential of the research to advance science and medicine. The recipients will receive various siRNA, shRNA and microRNA reagents from the Dharmacon and Open Biosystems RNAi technology portfolios, marketed under the Thermo Scientific brand.

D. Borden Lacy, assistant professor, and Terence S. Dermody, professor of pediatrics, microbiology and immunology at Vanderbilt University, will receive a whole genome small-interfering RNA (siRNA) screening package to investigate pathogen cell entry. These researchers hope to identify host proteins that form networks required for diverse microbial pathogens (viruses and bacterial exotoxins) to enter living cells. They expect these networks to open new avenues for research into host-pathogen interaction and point to new drug targets.

“We are honored to receive an RNAi Discovery Grant from Thermo Fisher Scientific,” said Dermody. “It will allow us to combine our efforts in studies of how bacterial toxins and viruses gain entry into host cells and may lead to development of new classes of antimicrobial agents.” Lacy added, “We would not have been able to do this work without the RNAi Discovery Grant, and we are excited to get started.”

Roger Lippe, associate professor, in the Department of Pathology and Cell Biology at the University of Montreal, will receive a custom siRNA sub-library targeting human genes. The sub-library will be used to identify cellular proteins interacting with HSV-1 (herpes simplex virus type 1). The goal is to identify host proteins implicated in propagation of HSV-1 and understand their relevance and function for the virus.

Caitlin Conboy, graduate student and David Largaespada, professor of the Masonic Cancer Center and Center for Genome Engineering, University of Minnesota, will receive a custom short-hairpin RNA (shRNA) sub-library targeting human genes. Using results from a transposon-based genetic screen, they will use shRNA to functionally validate genes required for generation and growth of tumors in colorectal cancer.

A set of human colorectal cancer and normal colonic epithelium cell lines will be treated with shRNA and then analyzed for alterations in the Wnt/beta-catenin pathway, including signaling, proliferation, cell cycle, apoptosis, invasion and anchorage-independent growth. The team expects to identify both positive and negative regulators of tumor production, which ultimately may point to candidates for drug targeting.

Christopher J. Lord, senior staff scientist, and Alan Ashworth, professor and director of the Breakthrough Breast Cancer Research Centre at The Institute of Cancer Research in London, will receive a microRNA (miRNA) library to optimize new cancer drugs that show promise in treating certain types of breast and ovarian cancer.

In clinical tests, these drugs, known as PARP inhibitors, have been successful in shrinking tumors in many patients without the side effects associated with standard chemotherapies. The researchers hope to identify miRNAs that affect a patient’s response to PARP inhibitors and then develop clinical biomarkers to predict which patients are more likely to respond favorably or be resistant to the drugs.

"It's been clear to us for some time now that genetic screens are incredibly useful in helping us understand many of the complex issues in cancer biology and treatment,” said Lord. “The RNAi screening reagents that Thermo Fisher has developed are key to this genetic approach, and we know that these days one can translate the findings from an RNAi screen very rapidly into something that is clinically relevant.”

Xiaofeng Zhou, assistant professor at the University of Illinois in Chicago, will receive a miRNA library to identify microRNAs that contribute to enhanced cancer cell invasion and migration. An essential characteristic of cancer is the ability to invade surrounding tissues and metastasize to regional and distant sites. Several recent studies suggest links between metastasis, which is the most deadly aspect of cancer, and unique microRNA changes. Zhou will specifically study head and neck cancer cell lines with different metastatic potential, and his goal is determine if microRNA deregulation affects this potential.

“We are delighted that our RNAi Discovery Grant program will advance research into key areas of medical science,” said Mitchell Kennedy, vice president and general manager, Thermo Scientific Genomics. “These RNAi screening technologies will help accelerate important biological discoveries that may lead to better treatments for some of the most devastating diseases facing humanity.”

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Biodesign Institute, Thermo Fisher Partner on $9M Radiation Test
Partnership enters a new, $9M phase of a project to produce a diagnostic test to rapidly measure an individual’s level of absorption of ionizing radiation.
Wednesday, June 04, 2014
Thermo, Nuclea Biotechnologies Collaborate to Develop Diabetes Markers
Companies pooling their expertise to develop novel multiplexed research methods for high-throughput quantification of native insulin and its therapeutic analogs.
Monday, June 02, 2014
Thermo Fisher Scientific Announces 4th Annual Cellome Award Winner
Vishal Deshmukh, Scripps Institute to accept award for excellence in the application of high content technology in Multiple Sclerosis research.
Wednesday, February 26, 2014
Thermo Reports 6% Q4 Revenue Growth
Thermo Fisher Scientific Inc. reported its financial results for the fourth quarter and full year ended December 31, 2013.
Friday, January 31, 2014
One Lambda Receives CE Mark Approval for C1qScreen
Assay cited in New England Journal of Medicine for use in determining impact on kidney graft survival.
Tuesday, November 19, 2013
Thermo Scientific Selected to Supply Maybridge Fragment Library for Key Research
Recommended for use by renowned fragment library design expert.
Tuesday, February 05, 2013
Record Revenues for Thermo Fisher Scientific
Revenue for the quarter grew 6% to $3.26 billion in 2012, versus $3.09 billion in 2011.
Thursday, January 31, 2013
Thermo Scientific Enters into a Long-Term Agreement with Fujirebio
Combination of Thermo Scientific B•R•A•H•M•S PCT assay and Lumipulse platforms to test patients suspected of having sepsis.
Thursday, November 22, 2012
Thermo Fisher Scientific Announces Application Deadlines for Life Sciences Scholarships
Thermo Scientific Pierce Scholarship Winter/Spring semester applications due December 14, 2012.
Wednesday, November 14, 2012
Thermo Fisher Scientific Introduces Guide to Good Washing Practice
The online guide is designed to provide detailed guidance on obtaining secure and reliable performance with every use of the Thermo Scientific Wellwash microplate washers.
Thursday, October 21, 2010
Thermo Fisher Scientific Launches Maybridge Ro3 Diversity Fragment Library
Diverse set of 1,500 molecules engineered for high-quality fragment screening-based programmes.
Tuesday, July 06, 2010
Thermo Fisher Scientific Signs Agreement to Acquire B.R.A.H.M.S. AG
Company acquires provider of specialty in-vitro diagnostic tests for $470 million USD.
Monday, September 07, 2009
Thermo Fisher Scientific to Showcase Innovative Mass Spectrometry Solutions at IMSC 2009
Company will showcase a variety of mass spectrometry software and hardware solutions to deliver improved analytical performance.
Monday, September 07, 2009
Thermo Fisher Scientific Implements LIMS for the Food and Environment Research Agency
Fera uses Thermo Scientific Nautilus to manage critical laboratory data and processes.
Thursday, September 03, 2009
Thermo Fisher Scientific Goes Global with Food Safety Seminar Series
The global seminar program will take place across the U.S., Canada, Europe, Southeast Asia and Japan to explore global perspectives on food safety.
Friday, August 28, 2009
Scientific News
High Throughput Mass Spectrometry-Based Screening Assay Trends
Dr John Comley provides an insight into HT MS-based screening with a focus on future user requirements and preferences.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Potential Persistent Tuberculosis Treatment
Researchers have discovered several first-in-class compounds that target hidden TB infections by attacking a critical process the bacteria use to survive in the hostile environment of the lungs.
Metabolic Profiles Distinguish Early Stage Ovarian Cancer with Unprecedented Accuracy
Studying blood serum compounds of different molecular weights has led scientists to a set of biomarkers that may enable development of a highly accurate screening test for early-stage ovarian cancer.
The Do’s and Don’ts of SPR Experiments
Surface Plasmon Resonance (SPR) is a technique that is becoming more widely used, particularly by anyone who wants to obtain accurate on (association) and off (dissociation) rates for biomolecular binding.
Long-Sought Protein Sensor for the ‘Sixth Sense’ Discovered
In a study led by scientists from The Scripps Research Institute (TSRI)the sensor protein for propioception has been identified.
New Anti-Malarial Drug Screening Model
University of South Florida researchers demonstrate novel chemogenomic profiling to identify drug targets for the most lethal strain of malaria.
Shedding Light on “Dark” Cellular Receptors
UNC and UCSF labs create a new research tool to find homes for two orphan cell-surface receptors, a crucial step toward finding better therapeutics and causes of drug side effects.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Giant Molecules Inhibit Ebola Infection
European researchers have designed a "giant" molecule formed by thirteen fullerenes covered by carbohydrates which, by blocking this receptor, are able to inhibit the cell infection by an artificial ebola virus model.

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos